Injectable Filler for Cheek Flattening

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

August 31, 2010

Primary Completion Date

August 31, 2011

Study Completion Date

October 31, 2011

Conditions
Malar Deficiency
Interventions
DRUG

Calcium hydroxylapatite

Subjects will be treated to full correction at visit 1 and, if needed, a touch-up injection at 2 weeks.

Trial Locations (1)

60611

DeNova Research, Chicago

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Merz Aesthetics Inc.

INDUSTRY

lead

DeNova Research

OTHER